Andrea Coluccio

Andrea Coluccio, PhD, is a Research Strategy Analyst at ITM Isotope Technologies Munich SE, with extensive experience in translational medicine and drug discovery. Previously, Andrea held positions as Senior Scientist and Lab Head at Medigene AG, where contributions included analytical assay development and successful regulatory submissions for T cell therapies. Prior roles include Scientist at Fraunhofer ITEM, where Andrea focused on drug discovery using patient-derived models, and postdoctoral research at the Technical University Munich and EPFL, working on pancreatic cancer research and genomic imprinting. Academic qualifications include a PhD from EPFL and a Master's degree in Medical Biotechnology from Università degli Studi di Modena e Reggio Emilia.